PERSPECTA

News from every angle

← Back to headlines

Corvus outlines cash runway into Q2 2028 and targets mid-2027 Phase II readout for soquelitinib in atopic dermatitis

13 Mar, 01:32 — 13 Mar, 01:32
PostShare

Sources

Showing 1 of 1 sources